Free Trial

Cantor Fitzgerald Comments on RenaissanceRe FY2025 Earnings

RenaissanceRe logo with Finance background

Key Points

  • Cantor Fitzgerald has revised its FY2025 EPS estimate for RenaissanceRe Holdings to $30.09 per share, up from $26.53, while maintaining a "Hold" rating on the stock.
  • RenaissanceRe reported $12.29 earnings per share for the last quarter, surpassing estimates by $2.01, despite a revenue decline of 2.4% year-over-year.
  • The company announced a quarterly dividend of $0.40, resulting in an annual yield of 0.6%, with a payout ratio of 4.09%.
  • Five stocks we like better than RenaissanceRe.

RenaissanceRe Holdings Ltd. (NYSE:RNR - Free Report) - Cantor Fitzgerald increased their FY2025 EPS estimates for RenaissanceRe in a research note issued to investors on Thursday, October 9th. Cantor Fitzgerald analyst R. Tunis now expects that the insurance provider will post earnings of $30.09 per share for the year, up from their previous forecast of $26.53. Cantor Fitzgerald has a "Hold" rating on the stock. The consensus estimate for RenaissanceRe's current full-year earnings is $26.04 per share.

Other equities analysts have also issued reports about the company. Wolfe Research initiated coverage on RenaissanceRe in a report on Monday, September 15th. They set a "peer perform" rating for the company. Wells Fargo & Company upped their price objective on RenaissanceRe from $269.00 to $278.00 and gave the stock an "equal weight" rating in a research note on Wednesday, October 8th. Barclays set a $278.00 price target on shares of RenaissanceRe in a research report on Wednesday. Weiss Ratings restated a "buy (b)" rating on shares of RenaissanceRe in a research report on Wednesday, October 8th. Finally, Citigroup initiated coverage on shares of RenaissanceRe in a research report on Wednesday, August 13th. They issued a "buy" rating and a $288.00 target price for the company. Four investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $285.55.

Check Out Our Latest Report on RenaissanceRe

RenaissanceRe Price Performance

Shares of NYSE:RNR opened at $260.19 on Monday. The company has a market cap of $12.25 billion, a PE ratio of 6.65, a P/E/G ratio of 2.33 and a beta of 0.27. The firm has a 50-day simple moving average of $246.33 and a 200 day simple moving average of $243.18. RenaissanceRe has a fifty-two week low of $219.00 and a fifty-two week high of $300.00. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.23.

RenaissanceRe (NYSE:RNR - Get Free Report) last released its earnings results on Wednesday, July 23rd. The insurance provider reported $12.29 earnings per share for the quarter, beating the consensus estimate of $10.28 by $2.01. RenaissanceRe had a net margin of 15.44% and a return on equity of 15.00%. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.96 billion. During the same quarter in the previous year, the firm earned $12.41 earnings per share. The firm's revenue for the quarter was down 2.4% compared to the same quarter last year.

RenaissanceRe Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Monday, September 15th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Monday, September 15th. RenaissanceRe's dividend payout ratio is currently 4.09%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD boosted its holdings in shares of RenaissanceRe by 37.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,496,035 shares of the insurance provider's stock valued at $599,049,000 after acquiring an additional 676,125 shares in the last quarter. Boston Partners boosted its stake in RenaissanceRe by 4.6% during the first quarter. Boston Partners now owns 2,106,207 shares of the insurance provider's stock valued at $505,509,000 after buying an additional 92,825 shares in the last quarter. Cooke & Bieler LP boosted its stake in RenaissanceRe by 18.0% during the first quarter. Cooke & Bieler LP now owns 1,247,742 shares of the insurance provider's stock valued at $299,458,000 after buying an additional 190,139 shares in the last quarter. Impax Asset Management Group plc boosted its stake in RenaissanceRe by 11.2% during the second quarter. Impax Asset Management Group plc now owns 1,220,038 shares of the insurance provider's stock valued at $295,494,000 after buying an additional 122,732 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in RenaissanceRe by 17.6% during the second quarter. Bank of America Corp DE now owns 803,547 shares of the insurance provider's stock valued at $195,182,000 after buying an additional 120,063 shares in the last quarter. 99.97% of the stock is currently owned by institutional investors.

About RenaissanceRe

(Get Free Report)

RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S.

See Also

Earnings History and Estimates for RenaissanceRe (NYSE:RNR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in RenaissanceRe Right Now?

Before you consider RenaissanceRe, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RenaissanceRe wasn't on the list.

While RenaissanceRe currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.